Geneos Wealth Management »

Protalix Biotherapeutics shares owned by Geneos Wealth Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Geneos Wealth Management from 13F filings

Historical chart of Geneos Wealth Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Geneos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Geneos Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9k 800 2.33
2023-09-30 $3.3k 2.0k 1.66

More positions owned by Geneos Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S P 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Russell 3000 Etf (IWV)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Spdr Ser Tr Portfolio S&p500 (SPYM)
Apple (AAPL)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Norfolk Southern (NSC)
NVIDIA Corporation (NVDA)
Putnam Etf Trust Focused Lar Cap (PVAL)
Ishares Tr Core Msci Total (IXUS)
Spdr Ser Tr Portfoli S&p1500 (SPTM)

View all positions for Geneos Wealth Management

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics